Pancreatic Cancer Research

ResearcherNational Yang Ming Chiao Tung UniversityActive in the last 2 years

Pei‐Hung Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5006-0277; OpenAlex author ID A5004913185. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2018: 2 papers · 2019: 6 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 11

  1. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis. Co-author DOI 10.1002/advs.202306373↗
  2. External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience… Co-author DOI 10.1016/j.pan.2019.11.001↗
  3. Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemothera… Co-author DOI 10.1111/jgh.14926↗
  4. Effect of S-1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7-year multicenter observational cohort study in Taiwan. Co-author DOI 10.1002/cam4.2094↗
  5. Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic … First author DOI 10.1002/cam4.2254↗
  6. Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy. Co-author DOI 10.1002/cam4.2483↗
  7. Evolution of the chemotherapeutic landscape and survival outcome in patients with metastatic pancreatic cancer: a four-institute cohort study in Taiwan, 2010-2… Last author DOI 10.2147/cmar.s196300↗
  8. Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model. Co-author DOI 10.3390/cancers11010057↗
  9. Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. Co-author DOI 10.3390/jcm8091402↗
  10. Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy. Co-author DOI 10.3390/cancers10110432↗
  11. Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with E… Co-author DOI 10.3390/cancers10120501↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wen‐Chi Chou · 10 shared papers, 2018–2020 · strength 0.96
  2. Yen‐Yang Chen · 9 shared papers, 2018–2020 · strength 0.87
  3. Yu‐Shin Hung · 9 shared papers, 2018–2020 · strength 0.85
  4. Jen‐Shi Chen · 7 shared papers, 2018–2019 · strength 0.66
  5. Pei‐Wei Huang · 3 shared papers, 2019 · strength 0.28
  6. Keng-Hao Liu · 2 shared papers, 2019–2020 · strength 0.19
  7. Ching‐Fu Chang · 2 shared papers, 2019 · strength 0.19
  8. Martin Fleisher · 1 shared paper, 2024 · strength 0.15
  9. Hong Li · 1 shared paper, 2024 · strength 0.15
  10. Ya‐Chin Hou · 1 shared paper, 2024 · strength 0.15
  11. Chi‐Ling Chiang · 1 shared paper, 2024 · strength 0.15
  12. L. James Lee · 1 shared paper, 2024 · strength 0.15
  13. Chung‐Pin Li · 1 shared paper, 2024 · strength 0.15
  14. Yan‐Shen Shan · 1 shared paper, 2024 · strength 0.15
  15. Shao‐Ming Yu · 1 shared paper, 2020 · strength 0.11
  16. Chih–Chung Hsu · 1 shared paper, 2020 · strength 0.11
  17. Shu‐Hui Lee · 1 shared paper, 2019 · strength 0.09
  18. Hsiang‐Lan Lai · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.